Dietary potassium and the renal control of salt balance and blood pressure by Penton, David et al.








Dietary potassium and the renal control of salt balance and blood pressure
Penton, David ; Czogalla, Jan ; Loffing, Johannes
Abstract: Dietary potassium (K(+)) intake has antihypertensive effects, prevents strokes, and improves
cardiovascular outcomes. The underlying mechanism for these beneficial effects of high K(+) diets may
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ance. Indeed, several studies demonstrate that dietary K(+) intake induces renal Na(+) loss despite
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and Na(+) handling. Particular focus is given to findings suggesting that an aldosterone-independent
downregulation of the thiazide-sensitive NaCl cotransporter significantly contributes to the natriuretic
and antihypertensive effect of a K(+)-rich diet. Last but not least, we refer to the complex signaling
pathways enabling the kidney to adapt its function to the homeostatic needs in response to an altered
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Abstract Dietary potassium (K+) intake has antihypertensive
effects, prevents strokes, and improves cardiovascular out-
comes. The underlying mechanism for these beneficial effects
of high K+ diets may include vasodilation, enhanced urine
flow, reduced renal renin release, and negative sodium (Na+)
balance. Indeed, several studies demonstrate that dietary K+
intake induces renal Na+ loss despite elevated plasma aldoste-
rone. This review briefly highlights the epidemiological and
experimental evidences for the effects of dietary K+ on arterial
blood pressure. It discusses the pivotal role of the renal distal
tubule for the regulation of urinary K+ and Na+ excretion and
blood pressure and highlights that it depends on the coordi-
nated interaction of different nephron portions, epithelial cell
types, and various ion channels, transporters, and ATPases.
Moreover, we discuss the relevance of aldosterone and
aldosterone-independent factors in mediating the effects of
an altered K+ intake on renal K+ and Na+ handling. Particular
focus is given to findings suggesting that an aldosterone-
independent downregulation of the thiazide-sensitive NaCl
cotransporter significantly contributes to the natriuretic and
antihypertensive effect of a K+-rich diet. Last but not least, we
refer to the complex signaling pathways enabling the kidney
to adapt its function to the homeostatic needs in response to an
altered K+ intake. Future work will have to further address the
underlying cellular and molecular mechanism and to eluci-
date, among others, how an altered dietary K+ intake is sensed
and how this signal is transmitted to the different epithelial
cells lining the distal tubule.
Keywords Potassium . Aldosterone . NaCl cotransporter .
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Introduction
Based on observations in hypertensive patients, the Canadian
physician W.L.T. Addison suggested already in 1928 that the
“prevalence of arterial hypertension (…) is in large part due to
potash poor diet, and an excessive use of salt” [3]. Since then,
numerous epidemiological, observational, and interventional
studies in humans as well as experiments in animals con-
firmed that not only dietary sodium (Na+) but also potassium
(K+) intake may have profound effects on blood pressure [1,
61]. In modern societies, the average K+ intake is usually low
(70–80 mmol/day), while the average sodium (Na+) intake is
high (150–200mmol/day). This contrasts sharply with the diet
of our human ancestors who likely ate much more K+ (230–
300 mmol/day) and less Na+ (1–10 mmol/day) [22, 106]. The
change in human eating habits occurred within the last 5,000–
10,000 years, when humans started to process their food,
which lowered its content of K+ due to losses during cooking.
At the same time, Na+ intake increased due to artificial salting
in order to preserve food and to make it more palatable. In
evolutionary terms, 5,000–10,000 years are however rather
short and likely not sufficient to adapt our genetic make-up to
the new conditions. Therefore, our physiological settings are
more prepared for conditions when it was important to con-
serve Na+ and to excrete K+. The kidneys are the central
organs that maintain Na+ and K+ homeostasis [106]. They
are challenged with the complex task to independently match
Na+ and K+ excretion to variable dietary intakes and control
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blood pressure at the same time [124]. Healthy kidneys are
usually capable to fulfill these tasks. However, the current
high Na+ and low K+ content in our diet may have shifted
the functional capacity of the kidney to its physiological
limits. Small imbalances in renal function and/or in the under-
lying regulatory mechanism are then sufficient to deteriorate
the system and thus contribute to the high prevalence of
hypertension in our societies. The purpose of this review is
(i) to briefly summarize the evidence for the beneficial effect
of a K+-rich diet on blood pressure and cardiovascular out-
come, (ii) to briefly address the cellular and molecular mech-
anism bywhich the kidneys control Na+ and K+ excretion, and
(iii) to highlight recent data providing possible explanations
for the beneficial effect of dietary K+ on renal salt handling
and blood pressure control and on how these effects might be
mediated at the molecular level.
Effect of dietary K+ on blood pressure
An impressive body of evidence suggests that dietary K+
intake is inversely correlated with arterial blood pressure in
humans as well as in experimental animals (reviewed in [1, 2,
22, 61, 170]. Although few reports demonstrated that severe
K+ depletion in laboratory animals may decrease blood pres-
sure under certain conditions [7, 46], it is evident from studies
in humans that moderate dietary K+ restriction, as it occurs in
our diets, usually increases blood pressure [80, 83]. Converse-
ly, dietary K+ supplementation was shown to lower arterial
blood pressure in humans with essential hypertension [97,
125, 148, 169] and in rat models with spontaneous hyperten-
sion [34, 96] or experimentally induced hypertension due to
arterial stenosis [167] or dietary Na+-loading [32, 105, 168].
While most of these interventional studies were performed
with KCl supplementation, it remains controversial whether
the antihypertensive effect of a K+ diet is independent from the
accompanying ion [22]. Nevertheless, He and co-workers did
not find any differences between KCl and KHCO3 in their
antihypertensive effects [62]. Epidemiological studies have
also demonstrated the beneficial effect of dietary K+ on blood
pressure and cardiovascular morbidity and mortality. A strong
inverse association between arterial blood pressure and the
amount of urinary K+ excretion, used as surrogate of its
dietary intake, has been observed by several investigators [1,
22, 82]. The INTERSALT study did already suggest that
urinary K+ excretion is negatively and independently associ-
ated with arterial blood pressure in the general population
[71]. However, the number of participants was too small to
allow robust subgrouping and a sufficient analysis of the
impact of other possibly confounding factors. Very recently,
the Prospective Urban Rural Epidemiology (PURE) study
included blood pressure recordings, urinary ion excretion
values, and other health-relevant parameters from more than
100,000 adults from 18 countries [108]. After adjustment for
age, sex, geographic region, body mass index, alcohol con-
sumption, and educational level, the data showed a dominant
inverse relationship between systolic blood pressure and uri-
nary K+ excretion. With each gram increment of urinary K+
excretion, the associated systolic blood pressure dropped by
1.08 mmHg. Notably, this inverse correlation was seen irre-
spective from the amount of the urinary Na+ excretion and
hence from the estimated sodium consumption (Fig. 1a). As
Fig. 1 Effect of dietary Na+ and K+ on mean systolic blood pressure in
humans. aCorrelation of 24-h urinary Na+ and K+ excretion (as surrogate
for ion intake) with systolic blood pressure. Data were collected from
102,216 adults from 18 countries within the PURE study [108]. The P
value is for testing the joint effect of the two electrolytes on blood
pressure (from [108]). b Effects of Na+ and K+ dietary intake on the
mean systolic blood pressure. The study included 412 participants which
were randomly assigned to eat either a control diet or the fruit- and
vegetable-rich DASH diet.Within the assigned diet, participants ate foods
with either high, intermediate, or low levels of sodium for 30 consecutive
days (from [148])
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such, these data from an observational study are in line with
data from the interventional Dietary Approach to Stop Hyper-
tension (DASH) trial [148]. The DASH diet is rich in vegeta-
bles and fruits and part of its blood pressure-lowering effect can
likely be attributed to its high K+ content. Irrespective whether
this diet was combined with a high, intermediate, or low dietary
Na+ intake, it significantly reduced blood pressure. Neverthe-
less, the effect was more pronounced on the high than on the
low Na+ intake (Fig. 1b). Importantly, a high K+ diet does not
only lower blood pressure but does also decrease the risk for its
complications including cardiovascular events, stroke, and
death [2, 116]. In general, persons especially vulnerable to these
complications (e.g., obese persons, older persons, or patients
with hypertension) appear to profit most from the beneficial
effects of a K+-rich diet [108]. In contrast to the pronounced
effects seen in hypertensive patients, a high K+ intake does not
or only minimally decrease blood pressure of normotensive
humans and animals [12, 61, 170]. These evidences suggest
that dietary K+ interferes with the regulation of blood pressure
only when the balance in regulatory mechanisms is disturbed.
Moreover, there might be an optimal level of K+ intake up to
which the blood pressure-lowering effect could be achieved.
Indeed, experiments in Dahl salt-resistant and salt-sensitive rats
on a Na+ replete diet showed that the antihypertensive effect of
K+ supplementation occurred only with 2.6 % KCl. Treating
the animals with an excessive and unphysiological high K+
intake (4 and 8 % KCl) triggered a progressive rise in blood
pressure to levels even higher than those observed in rats on
low K+ (0.7 % KCl) intake [100]. As the increase in blood
pressure was paralleled by elevated plasma aldosterone levels,
it was suggested that aldosterone-dependent Na+ retention
could explain the hypertension. However, the inhibition of the
mineralocorticoid receptor by spironolactone was not able to
prevent the hypertensive effect of an excessive K+ intake in
mice [182].
The underlying mechanisms for the beneficial effect of a
physiologically relevant high K+ diet on blood pressure and
the cardiovascular system have been addressed in many re-
search studies (reviewed in [22, 170]). They were proposed to
include direct effects of altered plasma K+ levels on endothe-
lial cells leading to reduced endothelial stiffness and enhanced
nitric oxide (NO)-mediated vasodilation [118], endothelial
and vascular smooth muscle cell hyperpolarization and relax-
ation [22], an altered response of arterial baroreceptors [149],
a lowered sympathetic activity [52], a reduced renal renin
release [12], and a general negative sodium balance [70].
The latter is particularly interesting, given the fact that an
enhanced dietary K+ intake stimulates adrenal aldosterone
production, which is expected to promote Na+ retention rather
than to give rise for a Na+ loss. However, numerous experi-
mental studies in sheep [134, 135], dog [205], rat [179],
mouse [156], and human [79, 176] convincingly showed that
a K+ load is followed not only by a sustained kaliuresis but
also by a pronounced natriuresis. While the first parallels the
enhanced K+ intake, the latter usually exceeds the intake of
Na+ explaining the negative Na+ balance. The experiments in
sheep [134] and mice [156] showed that the K+-induced
natriuresis starts very rapidly and in parallel to the increasing
urinary K+ excretion. The natriuresis occurs independently
whether the K+ was given with the food or administered by
infusion [134, 135, 170]. Notably, the K+-dependent inhibi-
tion of renal Na+ reabsorption is accompanied by an enhanced
chloride excretion [171, 176] suggesting a combined renal
NaCl loss. Thus, there is a close interrelationship between
renal K+ and Na+ handling that likely also impacts on renal
blood pressure control.
Role of the distal tubule in the control of K+ and Na+
balance and blood pressure
K+ and Na+ are freely filtered at the glomerulus and then
reabsorbed to almost 90 % along the proximal tubule (PT)
and the thick ascending limb (TAL) [124, 136]. Thus, only
∼10 % of the filtered Na+ and K+ load reach the distal tubule
segments beyond the macula densa. However, these post-
macula densa segments, which include the distal convoluted
tubule (DCT), the connecting tubule (CNT), and the collecting
duct (CD) with its cortical (CCD) and medullary (MCD)
portion, are decisive for the amount of Na+ and K+ that gets
finally excreted via the urine [92, 106, 124, 136]. The molec-
ular identification of the major ion transporters and channels
of the distal tubule enabled researchers to map these proteins
along the DCT, CNT, and CD and to study their function at the
molecular level as reviewed in detail recently [5, 30, 142].
Despite some subtle species differences, the cellular distribu-
tion and sequential order of the ion-transporting and regulat-
ing proteins appear to be strikingly similar in all yet investi-
gated mammalian species (reviewed in [91]). The segmenta-
tion of the nephron and the various cell types of the distal
tubule including their main Na+ and K+ transporting pathways
are schematically depicted in Fig. 2.
In the initial 2/3 of the DCT (DCT1), the apical thiazide-
sensitive NaCl cotransporter (NCC) is almost the sole apical
Na+ transport pathway. In the last 1/3 of the DCT (DCT2),
NCC is co-expressed with the amiloride-sensitive epithelial
sodium channel (ENaC) [6, 91, 106]. ENaC is composed of
three homologous subunits (α,β, and γENaC) and is the main
apical sodium-reabsorbing pathway in the CNT and CD [92].
In contrast to NCC, the activity of ENaC is electrogenic and
generates a transepithelial potential difference that is crucial to
drive K+ secretion via apical K+ channels [18, 29]. K+ secre-
tion is accomplished by the renal outer medullary K+ channel
in the segment-specific principal cells of the DCT, CNT, and
CD [189, 192]. Interspersed between the segment-specific
cells are the intercalated cells, which are abundant from
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DCT2 to the first portion of the MCD. Intercalated cells
contribute to renal K+ secretion via apical Ca2+-dependent-
maxi K channels (BK) [64, 122]. BK channels are supposed to
mediate the flow-dependent K+ secretion in the distal tubule
and collecting duct [198]. BK is composed of a pore-forming
α-subunit and a modulatory β-subunit, for which four distinct
forms (β1−4) with tissue-specific expression have been de-
scribed [199].
The intercalated cells do also express an apical H+-K+-
ATPase that can reabsorb K+ from the tubular fluid in ex-
change for protons [31, 57]. As such, the intercalated cells are
capable for both K+ secretion and K+ reabsorption and likely
contribute to the ability of the DCT, CNT, and CD to switch
from K+ secretion during a high K+ intake to K+ reabsorption
during dietary K+ restriction [159]. Certain types of interca-
lated cells do also express an apical Cl-HCO3 exchanger
(pendrin) and a Na+-driven chloride/bicarbonate exchanger
(NDCBE), which were proposed to contribute to transcellular
NaCl reabsorption along the renal collecting system [37, 187].
Indeed, there is ample evidence for an important crosstalk and
cooperation between the segment-specific cells and intercalat-
ed cells and their ion transport pathways in order to maintain
Na+ and K+ homeostasis as well as a normal blood pressure
[37, 64, 194]. In the segment-specific cells of the DCT, CNT,
and CD, Na+ reabsorption and K+ secretion are driven by the
activity of the Na-K-ATPase in the basolateral plasma mem-
brane. By pumping Na+ towards the extracellular space and
K+ in the opposite direction, it keeps the intracellular Na+
concentration low and the intracellular K+ concentration high,
thereby providing the necessary ion gradients for the ion
fluxes across the apical membrane [194]. However, the inter-
calated cells express very little of the Na-K-ATPase [17], and
it remains unclear how these cells contribute to significant Na+
reabsorption and K+ secretion. It was recently postulated that
intercalated cells may rely on a H+ gradient generated by the
H+ vacuolar-ATPase as bioenergizer for secondary active
transport [23]. Moreover, immunohistochemical studies re-
vealed that the intercalated cells have a prominent abundance
of the Na-K-2Cl transporter NKCC1 in their basolateral plas-
ma membrane, which was proposed to ensure a sufficient
basolateral K+ uptake to fuel K+ secretion via apical BK
channels [89].
The functional relevance of the DCT, CNT, and CD for the
control of Na+ and K+ homeostasis as well as blood pressure is
evidenced by human monogenic diseases affecting ion trans-
port in these three segments (reviewed in, e.g., [142, 193]).
Loss-of-function mutations of NCC cause Gitelman’s syn-
drome which is characterized by renal Na+ loss with arterial
hypotension, hypokalemic alkalosis, and hypocalciuria [76,
87, 155]. Conversely, increased NCC activity due to muta-
tions within the regulatory network including the With-No-
lysine (K)WNK kinasesWNK1 orWNK4 [196] or ubiquitin-
ligase co-factors cullin-3 (CUL3) [14] and kelch-like 3 protein
(KLH3) [14, 95] is associated with severe salt-sensitive
BAFig. 2 a Schematic
representation of a nephron.
Highlighted with color is the
distal nephron including the distal
convoluted tubule (DCT) with an
early and late portion (DCT1 and
DCT2, respectively), the
connecting tubule (CNT), and the
collecting duct (CD). The gray
rectangles indicate the
distribution of intercalated cells
(IC). b Schematic cell models
with representation of the main
apical and basolateral transport
pathways contributing to Na+
reabsorption and K+ secretion in
the respective tubule segment.
Abbreviations for the ion
channels, transporters, and
ATPases are explained in the text
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hypertension, hyperkalemia, metabolic acidosis, and hyper-
calciuria (familial hyperkalemic hypertension (FHHt), Gor-
don syndrome, or pseudohypoaldosteronism type II). Like-
wise, loss-of-function mutations in ENaC cause severe renal
salt-wasting with often life-threatening hyperkalemia and ac-
idosis (pseudohypoaldosteronism type I) [24, 161], while
gain-of-function mutations of ENaC (Liddle syndrome) are
associated with salt-sensitive arterial hypertension with hypo-
kalemic alkalosis [59, 60, 153]. Remarkably, although these
diseases primarily affect Na+ transporting pathways, they also
affect renal K+ handling and in part also renal Ca++, Mg++, and
acid/base excretion, further emphasizing the important inter-
relation of these ion transport processes in the distal tubule.
Transgenic mouse models for Gitelman syndrome [151],
FHHt [81, 166, 203], PHA-I [11, 68, 103], and Liddle syn-
drome [132] have been generated and mimic to a large extent
the human diseases. This review will not discuss these models
but briefly highlight only those mouse models with deletion
for K+-transporting proteins for which corresponding human
diseases have not been described or for which the mouse
models show relevant differences from the human phenotype.
Knockout mouse models for the apical secretory potassium
channels ROMK [94, 185] and BK [16, 131, 150] as well as
for the gastric and colonic isoform of the H-K-ATPase [107,
157] have been developed. The phenotype of the ROMK-
deficient mice is dominated by the transport defect in the thick
ascending limb. Here, ROMK-dependent K+ secretion is im-
portant to provide a sufficient intratubular K+ concentration to
ensure the activity of the apical furosemide-sensitive Na-K-
2Cl cotransporter NKCC2. Consistent with a loss of NKCC2-
dependent Na+ reabsorption, the mice show a severe Bartter-
like syndrome with a high perinatal lethality and poor urinary
concentration ability. In contrast to patients with Bartter syn-
drome, the ROMK-deficient mice do not show hypokalemic
alkalosis but metabolic acidosis likely resulting from the
severe polyuria with subsequent hydronephrosis and renal
insufficiency [94]. As such, these mice could not be used to
study the role of ROMK for renal K+ secretion in the DCT,
CNT, and CD. However, the observation that infants with
Bartter syndrome due to ROMK mutations are usually
hyperkalemic and not hypokalemic as patients with mutations
in other Bartter syndrome-related genes (i.e., NKCC2, ClC-K,
barrtin, and the calcium-sensing receptor) [72] point to the
relevance of ROMK for renal K+ excretion.
The role of BK channels for renal K+ excretion and blood
pressure control has been studied using knockout mouse
models for its subunits [64]. BKα-deficient mice featured an
impaired flow-dependent urinary K+ secretion and
hyperaldosteronism probably to compensate for the disturbed
renal K+ secretion [138]. Likewise deletions of the ancillary
BKβ1 and BKβ4 subunits results in insufficient renal K+
excretion, hyperaldosteronism, and arterial hypertension [56,
63]. However, the effect of BKβ1 deletion on aldosterone
release and blood pressure critically depends on the genetic
background of the mice and the physiological role of this
subunit remains elusive [147]. The experiments in ROMK-
deficient and in BK-deficient mice did also reveal that both
channels may compensate for each other [8, 138]. This may
explain the rather mild defect in renal K+ excretion observed
in these mice.
Other putative players in the renal handling of K+ are the
gastric (HKα1) and colonic (HKα2) isoforms of the H+-K+-
ATPase. Renal H+-K+-ATPases are expressed throughout the
kidney, and their expression is profoundly upregulated by
dietary K+ restriction, suggesting that they may contribute to
renal K+ homeostasis [31, 57]. Besides the clear deficits in
gastric and colonic functions displayed by H+-K+-ATPase
knockout mice (including gastric achlorhydria and epithelial
metaplasia (HKα1 knockout mice) [157] and insufficient
colonic K+ reabsorption under dietary K+ restriction (HKα2
knockout mice) [107]), no overt renal phenotype has been
reported so far. Further studies are warranted to elucidate their
role in renal physiology as detailed in two recent review
articles [31, 57].
Effect of K+ intake on K+ and Na+ transport in distal
tubules
The vast majority (∼98 %) of the K+ content of the body (∼3,
500 mmol) is stored inside the cells. Only a small amount of
K+ (70–100 mmol) is found in the extracellular space. Thus,
the standard daily K+ intake of humans (∼100 mmol) just
equals the amount of extracellular K+ [55]. In smaller mam-
mals, like the mouse, the standard daily K+ intake may even
exceed the amount of extracellular K+ up to a factor of 40
[156]. The fact that under these conditions, a single meal does
not cause a life-threatening increase of the extracellular K+
concentration is mainly due to (i) a rapid shift of extracellular
K+ into intracellular stores (internal K+ balance) and (ii) a
rapid onset of K+ excretion via the kidney and to less extent
also via the colon (external K+ balance) [119]. In the kidney,
the increase in urinary K+ excretion is achieved via an activa-
tion of both apical K+ channels and Na+ channels, as well as
the basolateral Na+-K+-ATPase [189]. Electrophysiological
data on isolated collecting ducts demonstrated that an en-
hanced dietary K+ intake increases the number of active K+
and Na+ channels in the apical membrane rather than changes
the open probability and/or conductance of single channels
[120, 121]. Immunofluorescence studies and/or in vivo cell
surface biotinylation assays corroborated these findings and
showed that the increase in the number of active channels is
due to a translocation of BK [112], ROMK [50, 173, 183], and
ENaC [50, 173] from intracellular pools to the apical plasma
membrane. The activation of ROMK and ENaC in response to
dietary K+ loading occurs quite rapid and was suggested to
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contribute to the renal adaptation to day-to-day variations in
dietary K+ intake [121]. The K+ diet-induced activation of BK
is paralleled by an enhanced mRNA expression of the BKα
and BKβ2-4 subunits [112] and BKα protein abundance [90,
138]. The latter is possibly related to a reduced ERK1/2
signaling-mediated lysosomal degradation of the channel
[90]. In contrast, the activation of ROMK is not associated
with an increased ROMK transcription [51] but goes along
with an enhanced abundance of its fully glycosylated form
suggesting an increased processing of ROMK through the
Golgi apparatus [50]. ENaC does also undergo post-
translational modification. The K+ diet-induced activation of
ENaC is accompanied by a proteolytic cleavage of the α- and
γENaC subunits and a shift of βENaC to higher molecular
weight forms consistent with an altered glycosylation pattern
[50]. While the significance of the latter is unclear, the pro-
teolytic cleavage of α- and γENaC is thought to represent the
activation of otherwise silent channels [143]. It is important to
note that, in contrast to ENaC [47, 102], the K+ channels BK
[40] and ROMK [120] do not get activated in response to
dietary Na+ restriction, suggesting that increased plasma aldo-
sterone levels are per se not sufficient to bring the K+ channels
to the apical plasma membrane. The differential regulation of
ENaC and ROMK in response to dietary Na+ restriction and
K+ loading (Fig. 3) may contribute to the ability of the kidney
to independently regulate Na+ and K+ homeostasis. Notably,
the apical translocation of ROMK [183] and ENaC [106, 173]
in response to dietary K+ loading occurs mainly in the late
DCT (DCT2) and early CNT. These findings are in line with
early micropuncture studies suggesting that renal K+ excretion
is mainly achieved at these sites [99]. Consistent with a high
K+ transport capacity, the late DCT and early CNT are char-
acterized by a high density of the Na-K-ATPase and of mito-
chondria (reviewed in [106]). The activity of ENaC in these
segments is much more pronounced than in the downstream
localized CD [48, 114]. The critical role of the late DCT and
CNT for maintenance of K+ and Na+ homeostasis has been
extensively discussed in several recent reviews [92, 106, 123]
and is underlined by the fact that mice with targeted inactiva-
tion of ENaC in the CCD are phenotypically normal [145],
while mice with targeted inactivation of ENaC in the CNT
show an impaired control of K+ and Na+ homeostasis [29].
Although recent experiments in rats suggested that part of
the K+ secretion in response to a dietary K+ load occurs
independent from ENaC [49], the upregulation of this electro-
genic Na+ reabsorption certainly supports renal K+ secretion.
As mentioned earlier in this review, the activity of ENaC is
necessary to generate a transepithelial potential difference that
drives K+ apical secretion [18, 29]. However, the increased
Na+ reabsorption in the distal tubule is at odds with the
described natriuretic and antihypertensive effect of a K+-rich
diet. A possible explanation for this apparent paradox comes
from recent observations on the effect of dietary K+ intake on
the activity of NCC in the DCT [156]. An oral K+ load by
gastric gavage or feeding rapidly (<15 min) dephosphorylates
and hence inactivates the thiazide-sensitive NaCl
cotransporter NCC. This response parallels the K+-induced
kaliuresis and natriuresis (Fig. 4) and precedes a detectable
activation of ENaC by proteolytic cleavage [156]. The K+
diet-induced NCC downregulation is also seen under chronic
ROMK
ENaC
Control High K+ (3%) Low Na+ (0.05%)Fig. 3 Effect of dietary K
+
loading and dietary Na+
restriction on the subcellular
localization of ROMK and
γENaC in mouse CNTs. Mice
were kept either for 1 week on a
control diet (0.8 % K+, 0.3 %
Na+), for 2 days on a high K+ diet
(3 % K+, 0.3 % Na+), or for
10 days on a low Na+ (0.8 % K+,
0.01 % Na+).
Immunohistochemical detection
of ROMK (in green) and γENaC
(in red)
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conditions (i.e., days to weeks of a high K+ diet) but concerns
mainly the total and cell surface-expressed NCC rather than its
phosphorylation [50, 73, 179, 182, 200]. Moreover, while the
acute effect on NCC appears to be independent from the co-
administered anion [156], the chronic effect on NCC abun-
dance and phosphorylation was reported to occur only when
the K+ is accompanied by chloride and not by citrate [20].
Notably, the downregulatory effect of a high K+ diet is inde-
pendent from dietary Na+ intake and is seen on standard Na+
[50, 175], high Na+ [182], and low Na+ intake [179]. These
findings are in agreement with early renal tubule micropunc-
ture studies on rats showing a diminished natriuretic response
to thiazides after dietary K+ loading [154]. Previous morpho-
logical studies had already revealed a reduced density of
mitochondria and basolateral membrane infoldings in DCTs
of rabbits on a low Na+/high K+ intake [75].
The downregulation of NCC in response to a high K+ diet
was proposed to improve the secretion of K+ in DCT2, CNT,
and CD due to the increased apical Na+ and fluid delivery [5,
104]. Na+ can be then reabsorbed in exchange for K+while the
enhanced urinary flow may activate flow-dependent K+ se-
cretion and lower intratubular K+, keeping the driving force
for K+ secretion high [192]. Nevertheless, it is unlikely that a
reduced activity of NCC is sufficient to increase urinary K+
excretion unless a sufficient number of active K+ and Na+
channels is present at the apical plasma membrane [26, 69].
However, given that thiazide diuretics [39] significantly lower
blood pressure, it is reasonable to assume that the observed
NCC downregulation in K+-repleted animals is sufficient to
contribute to the antihypertensive effect of a high K+ diet. On
the other hand, an upregulation of NCC may increase blood
pressure on a low K+ intake. In fact, studies in rats and mice
demonstrated that dietary K+ restriction increases the abun-
dance and phosphorylation of NCC [38] leading to renal Na+
retention and an elevated blood pressure [182]. However, it is
unlikely that the effects of an altered dietary K+ intake on renal
Na+ excretion and blood pressure control can be solely attrib-
uted to an altered NCC activity. In fact, although the K+-
induced natriuresis in NCC-deficient mice is diminished, they
still excrete more Na+ than NCC-deficient mice without any
K+ loading [156]. The nature of the remaining K+-induced
natriuresis in NCC-deficient mice is unclear but might be
related to inhibitory effects of K+ loading on Na+ transport
in the proximal tubule [15] and in the TAL [26, 78, 160, 164].
Consistently, an altered K+ intake may modulate also the
expression of ion transporters in the proximal tubule and the
Ctrl KCl Ctrl KClA
B
Fig. 4 Rapid effects of an oral K+
load on urinary ion excretion and
NCC phosphorylation. a Urine
K+ and Na+ concentrations
normalized to creatinine
concentrations from mice after
receiving a gastric gavage of
control (Ctrl; red; 0 % KCl) or
KCl (blue; 2 % KCl) solutions.
Spot urines were collected for the
indicated time intervals after
gavage. *P<0.05 and **P<0.01
between Ctrl and experimental
groups. #P<0.05 between the
“zero” and the time intervals
within the same experimental
group. b Male mice received
control (Ctrl) and 2 % KCl
solutions through gavage, and
kidneys were collected after 15,
30, and 120 min. Total NCC
(tNCC) and phosphorylation of
NCC at position 53 (pT53) were
assessed by immunoblotting with
specific antibodies. Error bars
indicate standard error of the
mean. (Graphs and immunoblots
from [156])
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TAL including NHE3 and NKCC2 as shown in some [38, 47,
73] but not all studies [115].
The role of aldosterone
Aldosterone is regarded as the main hormone mediating the
effects of K+ intake on the kidney while also regulating Na+
balance and contributing to blood pressure control. A high
dietary K+ intake increases plasma [K+], which promotes
aldosterone production and release from the zona glomerulosa
of the adrenal cortex [10]. The elevated plasma aldosterone
levels are then thought to stimulate renal K+ secretion until the
excess of K+ is excreted [55]. Indeed, aldosterone is known to
stimulate K+ secretion in the renal collecting system, and
several evidences suggest that it may interfere with the regu-
lation of most of the molecular players involved in distal
tubule K+ transport including ENaC [92], ROMK [186], BK
[195], and NCC [77, 177, 178]. However, the effects of
physiological elevations of plasma aldosterone on renal K+
excretion are rather minor and a dietary K+ load induces a
kaliuresis often already before plasma aldosterone levels get
elevated [133]. Moreover, adrenalectomized animals are able
to adapt their urinary K+ excretion and to increase apical Na+
and K+ conductances in the CD in response to a dietary K+
load [120, 158, 197]. Likewise, mice with a genetic inactiva-
tion of the aldosterone synthase maintain an adequate renal
adaptation to a physiological K+ load (2 % K+ diet). Only
when challenged with an unphysiological high (5 %) K+ diet,
the aldosterone synthase-deficient mice decompensate and
become severely hyperkalemic likely due to an insufficient
upregulation of ENaC rather than of ROMK [173]. The inde-
pendence of ROMK and BK activity from aldosterone could
be also deduced from the fact that these channels do not get
activated upon Na+ dietary restriction, despite the elevated
plasma aldosterone levels [40, 120, 121]. Moreover, aldoste-
rone does not increase K+ channel activity in a mouse CCD
cell line [45]. It was also shown that the K+ diet-induced
downregulation of NCC is aldosterone-independent [156].
Thus, there is ample evidence that in addition to aldoste-
rone, aldosterone-independent factors contribute to the renal
control of K+ homeostasis. A variety of additional hormones
were implicated in the regulation of renal K+ secretion, and
many of them do also control Na+ balance and blood pressure.
Indeed, glucocorticoids [43] and vasopressin [19, 44] stimu-
late renal K+ secretion. Part of their effect might be related to
their known activating effects on ENaC. Moreover, glucocor-
ticoids increase urinary flow and thereby may activate flow-
dependent K+ secretion [43], while vasopressin was reported
to directly activate ROMK [19]. Conversely, progesterone
gets increased during hypokalemia and was shown to stimu-
late renal K+ reabsorption via an increased H+-K+-ATPase
activity in the kidney [31, 36]. Angiotensin II suppresses the
activity of BK [211] and ROMK [191, 207] but stimulates
ENaC [165, 188] and NCC [21, 85, 177] and hence might be
critical to limit renal K+ secretion and to maximize renal Na+
reabsorption during hypovolemia [5]. Nevertheless, although
all of the abovementioned hormones likely contribute to the
modulation of the K+ response of the kidney, their described
physiological effects on renal K+ handling are comparably
small and unlikely account for the marked aldosterone-
independent regulations of, for example, ROMK and NCC
in response to a high K+ diet.
The existence of additional humoral kaliuretic factors has
been proposed since more than 25 years [146]. Although there
are evidences for the presence of such factors in blood [33]
and urine [98] of K+-loaded animals, their molecular identity
remains unclear. It has been proposed that the amount of
dietary K+ is already sensed in the gut and/or the portal vein
even before plasma K+ levels rise [55]. This would trigger the
release of kaliuretic peptides and/or modulate the activity of
the autonomous nervous system ultimately increasing renal
K+ excretion [55]. Similar feed-forward control systems in-
volving gut-derived peptides have been implicated in the
control of glucose and Na+ homeostasis [109]. Although
previous data suggested a gut-kidney crosstalk for the control
of K+ homeostasis [86], additional work is needed to further
substantiate this concept.
Changes in extracellular K+ concentrations may also di-
rectly affect renal ion transport. There is strong evidence that
increases in plasma K+ are already sufficient to stimulate renal
K+ and Na+ excretion [180], to increase the apical K+ conduc-
tance in distal tubules [43, 197], and to downregulate NCC in
the DCT [137]. K+ infusions into one renal artery of dogs
induce a prominent kaliuresis and natriuresis in the ipsilateral
kidney, while the contralateral kidney shows only mild
kaliuresis and no natriuresis [180]. One possible intrarenal
mediator could be tissue kallikrein (TK), which is a serine
protease synthesized in large quantities in the late DCT and
CNT [181]. TK synthesis and excretion into the urine is
increased by dietary K+ intake [181], and it activates ENaC
by proteolytic cleavage [126]. Nevertheless, the defect in renal
adaptation to a K+ load displayed by TK-deficient mice is
rather subtle [35], and the proteolytic cleavage of ENaC in
TK-deficient mice is only marginally changed [129].
Thus, there is a large body of experimental evidence sug-
gesting that aldosterone-dependent and aldosterone-
independent mechanisms contribute to the renal response to
a high K+ intake. Aldosterone is certainly not an absolute
prerequisite [192], but it is important to achieve a maximal
K+ secretion [101, 173]. Moreover, aldosterone may have an
important additional role. The aldosterone-dependent upregu-
lation of ENaC in the late DCT, CNT, and CD may not only
improve K+ secretion but may also limit the renal Na+ loss
caused by the inactivation of upstream Na+ transport systems.
As such, the increase of plasma aldosterone would contribute
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to maintain Na+ balance and hence finally blood pressure on
high K+ diet. The relevance of an intact aldosterone system in
this context is highlighted by experiments performed by
Young and co-workers in dogs [205]. While intact dogs
showed only a limited natriuresis and no significant change
in blood pressure in response to a K+ load, adrenalectomized
dogs with a fixed corticosteroid and aldosterone replacement
revealed a profound K+ intake-induced renal Na+ loss with a
marked drop in arterial blood pressure (Fig. 5). Thus, the K+
sensitivity of blood pressure may become overt only when
underlying feedback mechanisms of blood pressure control
are disturbed. This may also explain the observation that a
high K+ diet has a marked blood pressure-lowering effect only
in hypertensive but not in normotensive individuals (see
above).
The role of SGK1 and the WNK/SPAK pathway
In recent years, tremendous progress has been made in the
identification and characterization of molecular mechanisms
that regulate the ion transporters and channels involved in
renal Na+ and K+ handling in the DCT, CNT, and CD. This
research was summarized in several recent reviews [4, 54,
127, 162, 174, 192]. In brief, the current evidence suggests
that the regulation of Na+ and K+ transport in the post-macula
densa segments depends on an intricate regulatory network
that includes the interaction of several kinases (e.g.,WNK1, 3,
and 4, SPAK/OSR1, SGK1) [4, 54, 65], phosphatases, and
their regulators (e.g., PP1, PP4, I-1) [53, 88, 130] as well as
ubiquitin ligases (e.g., Nedd4-2, KLHL-3, cullin-3) [141,
174]. In the context of the renal adaptation to an altered dietary
K+ intake, the kinases SGK1, WNK1, and WNK4 receive
particular attention. SGK1 was proposed to mediate the
aldosterone-dependent effects of a high K+ diet [192]. In fact,
aldosterone [27, 113] and a high K+ intake [204] induce the
expression of SGK1. Moreover, SGK1 increases the cell
surface abundance and/or activity of apical and basolateral
players contributing to K+ secretion including ROMK [204,
207], BK [208], ENaC [93], and the Na-K-ATPase [209].
Consistent with the idea that SGK1 takes part in the renal
adaptation to a high K+ intake, SGK1-deficient mice show an
INTACT
ADX
Fig. 5 Intact dogs (n indicated in the bars) were kept for 2 days (C1–C2)
in metabolic cages with a control diet in which the K+ intake was fixed to
30mEq/day. After the second control day, additional 170 mEq/ KCl (total
200 mEq/day) was administered by a venous catheter connected to a
pump for the next 6 days (E1–E6). After this set of experiments, the dogs
were adrenalectomized (ADX) and supplemented with 50 μg/day of
aldosterone, and the experiment was repeated. In both experimental
setups, urinary Na+ and mean arterial pressure were measured. Hashtags
indicate statistical significance between the given measurement and C2.
Error bars indicate standard error of the mean. (Redrawn from [205])
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impaired renal K+ excretion and become hyperkalemic when
placed on a high K+ diet [67]. However, the underlying
molecular mechanisms are likely complex. In contrast to what
was expected, SGK1-deficient mice do not show a reduced
but rather an increased apical localization of ROMK [67].
Moreover, the effect of the loss of SGK1 on apical
ENaC activity is inconsistent. While an early study
[200] reported a reduced activity of ENaC in kidneys
of SGK1 knockout mice, a later study in a different
mouse model [42] reported unchanged apical ENaC
activity. Interestingly, SGK1-deficient mice reveal a re-
duced NCC abundance and phosphorylation that drops
even more during dietary K+ loading [175] and Na+
restriction [41]. The downregulation of NCC under stan-
dard conditions could be explained by the loss of the
stimulatory action of SGK1 on NCC [144], but the
further decrease of NCC on high K+ or low Na+ diet
is apparently SGK1-independent and perhaps secondary to the
developing hyperkalemia in these mice [41, 175]. Thus,
SGK1 likely contributes to the renal control of K+ balance,
but there is certainly a high degree of redundancy in the
underlying signaling pathways.
In these, WNK1 and WNK4 kinases may play a particular
role. The WNK kinases are serine/threonine kinases that were
implicated in a variety of functions in the body [4, 54]. The
relevance of these kinases for the renal control of Na+ and K+
balance and blood pressure is evidenced by the fact that
mutations in WNK1 and WNK4 cause familial hyperkalemic
hypertension (FHHt) (e.g., [54, 127] and see above). A great
body of experimental evidence suggests that the kidney-
specific short isoform of WNK1 (KS-WNK1) and the ubiq-
uitously expressed long isoform of WNK1 (L-WNK1) act
together with WNK4 in a complex cascade. KS-WNK1 an-
tagonizes the inhibitory effect of L-WNK1 on WNK4 [5, 54,
110]. In this concept, the balance between KS-WNK1 and L-
WNK1 and the activity mode of WNK4 are decisive for the
control of ion-transporting proteins in the distal tubule includ-
ing NCC, ROMK, and ENaC and hence for the physiological
adaptation of the DCT, CNT, and CD to altered dietary K+ and
Na+ intake [5, 54, 192]. The balance between KS-WNK1 and
L-WNK1 appears to be central for the adaptation of the kidney
to either a low K+ or a high K+ diet. On a low dietary K+
intake, the ratio of L-WNK1/KS-WNK1 increases [84] and
the excess of L-WNK1 is thought to cause an endocytotic
retrieval of ROMK [84] and an activation of both NCC [25,
163] and possibly ENaC [201]. The downregulation of
ROMK would directly limit K+ secretion in the distal tubule.
The upregulation of NCC would help to minimize K+ secre-
tion, by reducing the Na+ and fluid delivery to the downstream
localized segments. At the same time, the stimulatory effect of
L-WNK1 on ENaC partially counteracts the downregulation
of ENaC caused by the suppressed aldosterone levels due to
the low K+ intake. This may promote an inadequately high
Na+ reabsorption in the ENaC-positive distal tubules contrib-
uting to the hypertensive effect of a low K+ diet [66]. In
contrast, a high K+ diet lowers the ratio of L-WNK1/KS-
WNK1 [184] and the increased level of KS-WNK1 should
ultimately lead to a stimulation of ROMK [184] and inhibition
of NCC [58, 163]. Together with the aldosterone-dependent
activation of ENaC, this profoundly favors renal K+ secretion.
L-WNK1 and KS-WNK1 may also contribute to the control
of BK activity. Hadchouel et al. observed an enhanced BKα
protein abundance in KS-WNK1 knockout mice suggesting a
possible regulatory role of KS-WNK1 [58]. However, Cheng
et al. did not find any evidence for an altered BK channel
activity in collecting ducts of K+-loaded KS-WNK1-deficient
mice [28]. L-WNK1 was reported to activate BK, which may
alleviate L-WNK-1-dependent inhibition of ROMK [90].
At the same time, the WNK kinases may also allow to
independently adapt renal K+ and Na+ excretion and to ac-
count for the so-called aldosterone paradox [5]. Both a low
Na+ diet and a highK+ diet increase plasma aldosterone levels.
However, the primary physiological response elicited by al-
dosterone during dietary Na+ restriction is renal Na+ retention,
whereas during dietary K+ loading, the response is kaliuresis
[5]. WNK4 was proposed to act as an essential molecular
switch between these two states [74, 81]. Under standard
conditions, WNK4 inhibits NCC [74, 81, 202], ENaC [139,
206], ROMK [74, 84, 140], and BK [190, 208, 212] activity.
During dietary Na+ restriction, the elevated plasma aldoste-
rone and angiotensin II levels stimulate ENaC activity [92].
The elevated angiotensin II (Ang II) levels do also convert
WNK4 to a profound stimulator of NCC [21], which together
with the activation of ENaC maximizes renal Na+ retention.
At the same time, angiotensin II seems to stabilize the inhib-
itory activity of WNK4 on ROMK and thereby to minimize
renal K+ secretion [207]. During dietary K+ loading, ENaC is
also activated via aldosterone, but due to the unchanged
angiotensin II levels, WNK4 does not switch from inhibition
to activation of NCC [5]. Support for these hypotheses comes
from numerous experiments in vitro and in vivo (reviewed in
[4, 5, 54, 127, 162, 174, 192]) and the observation that dietary
Na+ and K+ intake indeed differentially modulate the renal
mRNA expression of KS-WNK1, L-WNK1, and/orWNK4 in
the expected directions [84, 117, 184]. Likewise, dietary Na+
and K+ intake were reported to modulate the protein abun-
dance of WNK4 as well as the abundance and phosphoryla-
tion of the downstream-acting kinase SPAK [137, 179, 182].
However, the results were not always consistent, and their
interpretation is complicated by the fact that WNK4 and
SPAK are expressed in several nephron portions, making
analyses on the whole organ level difficult. Moreover, altered
dietary K+ intake may not only change the abundance and
phosphorylation but also the subcellular localization of these
kinases [179], which may further contribute to the complexity
of this signaling pathway. Interestingly, a recent study using
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WNK4 knockout and SPAK knock-in mouse models sug-
gested that the regulation of NCC by ANG II but not by
dietary K+ depends on the integrity of the WNK4/SPAK
pathway [20], suggesting that the K+-induced effects on
NCC may involve additional molecular regulators.
The mechanism, by which an altered dietary K+ intake
interferes with the WNK pathway, begins to be unraveled.
There is evidence that changes in extracellular K+ concentra-
tion directly affect WNK1 expression and activity [111]. A
possible hypothesis for the explanation of such direct effects
comes from recent observations in a mouse model for the
human EAST/SeSAME syndrome [210]. The EAST/
SeSAME syndrome is caused by mutations in the KCNJ10
K+ channel that is expressed in certain neurons and in the
basolateral plasma membrane of the DCT. The patients suffer
from epilepsy, ataxia, sensorineural deafness, and a salt-
wasting renal tubulopathy that is similar to that seen in pa-
tients with Gitelman syndrome [9]. Consistently, KCNJ10-
deficient mice reveal a drastically reduced NCC abundance in
the kidney [210]. The authors proposed that the loss of the
KCNJ10-mediated K+ conductance depolarizes the cells and
decreases the electrochemical driving force for Cl− to exit
across the basolateral ClC-K Cl− channels. The subsequent
increase in intracellular Cl− concentration would ultimately
suppress SPAK and hence NCC activity [210]. Interestingly,
recent crystallographic data and mutational analysis suggested
that the WNK1 kinase domain comprises a Cl−-binding pock-
et. The binding of Cl− to this site would inhibit the autophos-
phorylation of WNK1 and thereby its kinase activity [128].
Likewise, Cl−-binding to a homologous binding pocket in
WNK4 may switch this kinase from an activator to an inhib-
itor of NCC phosphorylation and activity [13]. Thus, WNK1
and WNK4 may act as intracellular Cl− sensors that indirectly
sense changes in extracellular K+ concentrations. Support for
this model comes from recent experimental studies in
HEK293 cells which suggested that lowered extracellular
plasma K+ concentrations cause a KCNJ10-dependent hyper-
polarization of the plasma membrane. Such depolarization
increases Cl− efflux through ClC-Kb Cl− channels and finally
activates the WNK/SPAK pathway through the lowered intra-
cellular Cl− concentration [172]. Interestingly, WNK4 knock-
out mice and a knock-in mouse model expressing a mutant
form of SPAK that cannot be activated via WNK4 still re-
spond to a dietary K+ load with reduced NCC phosphorylation
[25]. These evidences suggest some redundancy in the signal-
ing mediating the effect of altered dietary K+ on NCC.
Conclusion
As outlined in this review, there are numerous complex inter-
actions between dietary K+ intake and the renal control of Na+
balance and blood pressure. Since the initial suggestion by
W.L.T. Addison, an impressive body of evidence confirmed
the beneficial effect of a high K+ diet on arterial blood pressure
and cardiovascular outcome. Studies in animal models linked
part of these effects to the inhibition of renal Na+ reabsorption,
which may involve a rapid inactivation of the thiazide-sensitive
NCC in the DCT. This thiazide-like effect of K+ may not only
lower arterial blood pressure but may also improve renal K+
excretion by increasing Na+ and fluid delivery to downstream
localized tubular segments. In addition to the pronounced effect
of dietary K+ on NCC, the downregulation of other ion trans-
port processes in the nephron also contributes to the natriuretic
and antihypertensive effect of a K+-rich diet. This may not only
include the inhibition of Na+ transport in the proximal tubule
and thick ascending limb but also effects on intercalated cells in
the renal collecting system. The role of the latter in blood
pressure control is receiving increasing attention, which is
further boosted by the recent demonstration that a high K+ diet
modulates the phosphorylation and hence the activity of the
mineralocorticoid receptor specifically in intercalated cells
[152]. Although the precise physiological impact of this effect
remains to be established, the findings further underline the
intricate interplay of different renal epithelial cell types in the
maintenance of ion homeostasis.
We just started to get insights into the molecular mecha-
nism by which an altered dietary K+ intake modulates the
activity of ion transporting pathways along the renal tubular
system. Particular roles appear to play the WNK kinases,
which are thought to act as molecular switches, allowing the
kidney to independently adapt urinary K+ and Na+ excretion
to functional needs. Nevertheless, important questions regard-
ing the interaction of these kinases with other signaling path-
ways in the context of an altered dietary K+ intake are still
unresolved. Moreover, although direct K+ sensing in adrenal
zona glomerulosa has been demonstrated, it remains elusive if
and how direct K+ sensing occurs in the kidney and perhaps in
other organs including the gut and by which mechanisms the
sensed information is transmitted to the renal epithelia and
their various membrane proteins involved in transepithelial
Na+ and K+ transport. The identification of aldosterone-
dependent and independent effects and the characterization
of their crosstalk are needed to better understand the complex
regulation of K+ and Na+ homeostasis and blood pressure
control. Eventually, this may help to develop novel strategies
to take advantage of the beneficial effects of a K+-rich diet that
does not only include the antihypertensive effects but also
reduced risks for urolithiasis and osteoporosis and an im-
proved glucose tolerance [61].
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